Laboratory Corporation of America Holdings

250.15+2.75+1.11%Vol 570.13K1Y Perf -10.09%
May 26th, 2022 16:00 DELAYED
BID248.01 ASK283.49
Open248.12 Previous Close250.15
Pre-Market- After-Market250.15
 - -  - -%
Target Price
326.00 
Analyst Rating
Strong Buy 1.31
Potential %
30.32 
Finscreener Ranking
★★★     49.17
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     50.43
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     62.42
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★     38.33
Price Range Ratio 52W %
21.30 
Earnings Rating
Strong Buy
Market Cap23.19B 
Earnings Date
28th Apr 2022
Alpha0.00 Standard Deviation0.08
Beta1.04 

Today's Price Range

248.12251.95

52W Range

232.01317.17

5 Year PE Ratio Range

10.1026.20

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
0.64%
1 Month
-1.14%
3 Months
-9.57%
6 Months
-13.53%
1 Year
-10.09%
3 Years
49.97%
5 Years
78.55%
10 Years
191.79%

TickerPriceChg.Chg.%
LH250.152.75001.11
AAPL143.783.26002.32
GOOG2 165.9249.13002.32
MSFT265.903.38001.29
XOM96.640.34000.35
WFC45.601.48003.35
JNJ179.46-0.1600-0.09
FB191.637.80004.24
GE77.012.48003.33
JPM129.442.20001.73
Financial StrengthValueIndustryS&P 500US Markets
1.60
2.00
0.36
0.59
14.30
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
33.20
18.60
23.20
15.20
13.28
RevenueValueIndustryS&P 500US Markets
15.86B
171.08
12.44
10.10
Earnings HistoryEstimateReportedSurprise %
Q01 20225.886.113.91
Q04 20215.906.7714.75
Q03 20214.776.8242.98
Q02 20215.646.138.69
Q01 20217.328.7920.08
Q04 20208.0510.5631.18
Q03 20205.298.4158.98
Q02 20200.782.57229.49
Earnings Per EndEstimateRevision %Trend
6/2022 QR4.820.42Positive
9/2022 QR4.512.04Positive
12/2022 FY19.901.84Positive
12/2023 FY18.06-0.22Negative
Next Report Date-
Estimated EPS Next Report5.88
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume570.13K
Shares Outstanding92.70K
Shares Float72.01M
Trades Count16.68K
Dollar Volume142.91M
Avg. Volume847.88K
Avg. Weekly Volume817.14K
Avg. Monthly Volume900.31K
Avg. Quarterly Volume826.20K

Laboratory Corporation of America Holdings (NYSE: LH) stock closed at 250.15 per share at the end of the most recent trading day (a 1.11% change compared to the prior day closing price) with a volume of 570.13K shares and market capitalization of 23.19B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 72400 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.

The one-year performance of Laboratory Corporation of America Holdings stock is -10.09%, while year-to-date (YTD) performance is -20.39%. LH stock has a five-year performance of 78.55%. Its 52-week range is between 232.01 and 317.17, which gives LH stock a 52-week price range ratio of 21.30%

Laboratory Corporation of America Holdings currently has a PE ratio of 11.40, a price-to-book (PB) ratio of 2.15, a price-to-sale (PS) ratio of 1.46, a price to cashflow ratio of 10.40, a PEG ratio of 2.32, a ROA of 10.49%, a ROC of 13.52% and a ROE of 20.80%. The company’s profit margin is 13.28%, its EBITDA margin is 23.20%, and its revenue ttm is $15.86 Billion , which makes it $171.08 revenue per share.

Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $5.88 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is -.

The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Strong Buy (1.31), with a target price of $326, which is +30.32% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Laboratory Corporation of America Holdings has a dividend yield of 1.15% with a dividend per share of $2.88 and a payout ratio of -%.

Laboratory Corporation of America Holdings has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.97, ATR14 : 6.75, CCI20 : 91.42, Chaikin Money Flow : 0.07, MACD : -2.92, Money Flow Index : 62.93, ROC : 3.95, RSI : 49.09, STOCH (14,3) : 87.55, STOCH RSI : 1.00, UO : 51.83, Williams %R : -12.45), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Amy B. Summy (Option Excercise at a value of $0), Amy B. Summy (Sold 249 shares of value $65 290 ), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), D. Gary Gilliland (Sold 500 shares of value $151 128 ), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $0), Jean-Luc Belingard (Option Excercise at a value of $0), Jeffrey A. Davis (Option Excercise at a value of $0), Judith C. Seltz (Option Excercise at a value of $0), Kathryn E. Wengel (Option Excercise at a value of $0), Kerrii B. Anderson (Option Excercise at a value of $0), Lance V. Berberian (Option Excercise at a value of $0), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 2 928 shares of value $809 932 ), Paul Kirchgraber (Option Excercise at a value of $0), Peter J. Wilkinson (Option Excercise at a value of $0), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert Sanders Williams (Option Excercise at a value of $0), Robert Sanders Williams (Sold 572 shares of value $156 145 ), Sandra D. van der Vaart (Option Excercise at a value of $763 740), Sandra D. van der Vaart (Sold 12 046 shares of value $3 377 606 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (75.00 %)
7 (77.78 %)
7 (70.00 %)
Moderate Buy
1 (12.50 %)
1 (11.11 %)
1 (10.00 %)
Hold
1 (12.50 %)
1 (11.11 %)
2 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.31
Strong Buy
1.28
Strong Buy
1.45

Laboratory Corporation of America Holdings

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.

CEO: Adam H. Schechter

Telephone: +1 336 229-1127

Address: 358 South Main Street, Burlington 27215, NC, US

Number of employees: 72 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

64%36%

Bearish Bullish

59%41%

TipRanks News for LH

Sun, 15 May 2022 16:35 GMT Analysts Top Healthcare Picks: Laboratory (LH), Medios AG (MEDOF)

- TipRanks. All rights reserved.

Sat, 30 Apr 2022 12:10 GMT Analysts Offer Insights on Healthcare Companies: Laboratory (LH), Resmed (RMD) and Anthem (ANTM)

- TipRanks. All rights reserved.

Mon, 25 Apr 2022 16:36 GMT Laboratory (LH) Received its Third Buy in a Row

- TipRanks. All rights reserved.

Tue, 15 Feb 2022 14:56 GMT Laboratory (LH) Receives a Buy from Mizuho Securities

- TipRanks. All rights reserved.

Mon, 14 Feb 2022 10:47 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Seagen (SGEN), Laboratory (LH) and Alnylam Pharma (ALNY)

- TipRanks. All rights reserved.

Fri, 11 Feb 2022 13:06 GMT Analysts Are Bullish on These Healthcare Stocks: Laboratory (LH), Marinus (MRNS)

- TipRanks. All rights reserved.

News

Stocktwits